Skip to main content
SpringerLink
Log in

Diagnosing Obesity, Diabetes Mellitus, and Insulin Resistance Syndrome

  • Chapter
Obesity and Diabetes

Part of the book series: Contemporary Diabetes ((CDI))

Abstract

Obesity is a disease state that has reached epidemic proportions, with increasing prevalence and serious health care consequences; therefore, it is important to diagnose and evaluate it properly. In this first part of the chapter, we present criteria for the diagnosis of overweight and obesity and evaluation of the obese and overweight patient and emphasize the importance of determining the specific type of obesity and the possible presence of other risk factors in obese individuals. We also review obesity-screening recommendations and rationale.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 249.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Flier JS, Flier FE. Obesity. In: Kasper A, Longo DL, Braunwald E, Hauser SL, Jameson JL, eds. Harrison’s Principle of Internal Medicine, 16th ed. McGraw-Hill, Medical Publisher Division, New York, 2005, pp. 422–430.

    Google Scholar 

  2. Obesity: Preventing and Managing the Global Epidemic. WHO Consultation on Obesity, Geneva, 1997.

    Google Scholar 

  3. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults—the evidence report. National Institutes of Health. Obes Res 1998;6(Suppl 2)51S–209S.

    Google Scholar 

  4. Kuczmarski RJ, Ogden CL, Grummer-Strawn LM, et al. CDC growth charts: United States. Adv Data 2000;(314):1–27.

    Google Scholar 

  5. Committee on Nutrition Status During Pregnancy and Lactation, Institute of Medice. Nutrition During Pregnancy, Weight Gain and Nutrient Supplements; Part I: Weight Gain. National Academies Press, Washington, DC, 1990.

    Google Scholar 

  6. Abrams B, Altman SL, Pickett KE. Pregnancy weight gain: still controversial. Am J Clin Nutr 2000;71(Suppl 5):1233S–1241S.

    PubMed  CAS  Google Scholar 

  7. Parker JD, Abrams B. Prenatal weight gain advice: an examination of the recent prenatal weight gain recommendations of the Institute of Medicine. Obstet Gynecol 1992;79(5)(Pt 1):664–669.

    PubMed  CAS  Google Scholar 

  8. Linne Y, Dye L, Barkeling B, Rossner S. Weight development over time in parous women—the SPAWN study—15 years follow-up. Int J Obes Relat Metab Disord 2003;27(12):1516–1522.

    Article  PubMed  CAS  Google Scholar 

  9. Pai MP, Paloucek FP. The origin of the “ideal” body weight equations. Ann Pharmacother 2000;34(9):1066–1069.

    Article  PubMed  CAS  Google Scholar 

  10. Harrison GG. Height-weight tables. Ann Intern Med 1985;103(6)(Pt 2):989–994.

    PubMed  CAS  Google Scholar 

  11. Pietrobelli A, Faith MS, Allison DB, Gallagher D, Chiumello G, Heymsfield SB. Body mass index as a measure of adiposity among children and adolescents: a validation study. J Pediatr 1998;132(2):204–210.

    Article  PubMed  CAS  Google Scholar 

  12. Maynard LM, Wisemandle W, Roche AF, Chumlea WC, Guo SS, Siervogel RM. Childhood body composition in relation to body mass index. Pediatrics 2001;107(2):344–350.

    Article  PubMed  CAS  Google Scholar 

  13. Hammer LD, Kraemer HC, Wilson DM, Ritter PL, Dornbusch SM. Standardized percentile curves of body-mass index for children and adolescents. Am J Dis Child 1991;145(3):259–263.

    PubMed  CAS  Google Scholar 

  14. Must A, Dallal GE, Dietz WH. Reference data for obesity: 85th and 95th percentiles of body mass index (wt/ht2) and triceps skinfold thickness. Am J Clin Nutr 1991;53(4):839–846.

    PubMed  CAS  Google Scholar 

  15. Rosner B, Prineas R, Loggie J, Daniels SR. Percentiles for body mass index in U.S. children 5 to 17 years of age. J Pediatr 1998;132(2):211–222.

    Article  PubMed  CAS  Google Scholar 

  16. Troiano RP, Frongillo EA Jr, Sobal J, Levitsky DA. The relationship between body weight and mortality: a quantitative analysis of combined information from existing studies. Int J Obes Relat Metab Disord 1996;20(1):63–75.

    PubMed  CAS  Google Scholar 

  17. Calle EE, Thun MJ, Petrelli JM, Rodriguez C, Heath CW Jr. Body-mass index and mortality in a prospective cohort of U.S. adults. N Engl J Med 1999;341(15):1097–1105.

    Article  PubMed  CAS  Google Scholar 

  18. Lean ME, Han TS, Seidell JC. Impairment of health and quality of life using new US federal guidelines for the identification of obesity. Arch Intern Med 1999;159(8):837–843.

    Article  PubMed  CAS  Google Scholar 

  19. Janssen I, Katzmarzyk PT, Ross R. Body mass index, waist circumference, and health risk: evidence in support of current National Institutes of Health guidelines. Arch Intern Med 2002;162(18):2074–2079.

    Article  PubMed  Google Scholar 

  20. Wong WW, Stuff JE, Butte NF, Smith EO, Ellis KJ. Estimating body fat in African American and white adolescent girls: a comparison of skinfold-thickness equations with a 4-compartment criterion model. Am J Clin Nutr 2000;72(2):348–354.

    PubMed  CAS  Google Scholar 

  21. Van der Kooy K, Seidell JC. Techniques for the measurement of visceral fat: a practical guide. Int J Obes Relat Metab Disord 1993;17(4):187–196.

    PubMed  Google Scholar 

  22. Bray GA. Clinical evaluation of the obese patient. Baillieres Best Pract Res Clin Endocrinol Metab 1999;13(1):71–92.

    Article  PubMed  CAS  Google Scholar 

  23. Bray GA, Ryan DH. Clinical evaluation of the overweight patient. Endocrine 2000;13(2):167–186.

    Article  PubMed  CAS  Google Scholar 

  24. McTigue KM, Harris R, Hemphill B, et al. Screening and interventions for obesity in adults: summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med 2003;139(11):933–949.

    PubMed  Google Scholar 

  25. McTigue K, Harris R, Hemphill MB, et al. Screening and Interventions for Overweight and Obesity in Adults. File Inventory, Systematic Evidence Review Number 21. December 2003. Agency for Healthcare Research and Quality of Rockville, MD. http://www.ahrq.gov/clinic/prev/obesinv.htm.

  26. Gray DS, Fujioka K. Use of relative weight and body mass index for the determination of adiposity. J Clin Epidemiol 1991;44(6):545–550.

    Article  PubMed  CAS  Google Scholar 

  27. Deurenberg P, Weststrate JA, Seidell JC. Body mass index as a measure of body fatness: age-and sex-specific prediction formulas. Br J Nutr 1991;65(2):105–114.

    Article  PubMed  CAS  Google Scholar 

  28. Knowler WC, Barrett-Connor E, Fowler SE, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002;346(6):393–403.

    Article  PubMed  CAS  Google Scholar 

  29. Buchwald H, Avidor Y, Braunwald E, et al. Bariatric surgery: a systematic review and meta-analysis. JAMA 2004;292(14):1724–1737.

    Article  PubMed  CAS  Google Scholar 

  30. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 2003;26(Suppl 1):S5–S20.

    Google Scholar 

  31. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2004;27(Suppl. 1):5–10.

    Google Scholar 

  32. Genuth S, Alberti KG, Bennett P, et al. Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 2003;26(11):3160–3167.

    Article  PubMed  Google Scholar 

  33. McCulloch DK. Definition and classification of diabetes mellitus. http://patients.uptodate.com/topic.asp?file=diabetes/9879.5-12-2004.

    Google Scholar 

  34. National Diabetes Data Group. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 1979;28(12):1039–1057.

    Google Scholar 

  35. Myers J, Zonszein J. Diagnosis and epidemiology of diabetes. In: Poretsky L, ed. Principles of Diabetes Mellitus. Kluwer Academic, Norwell, MA, 2002, pp. 95–106.

    Google Scholar 

  36. Mooy JM, Grootenhuis PA, de Vries H, et al. Intra-individual variation of glucose, specific insulin and proinsulin concentrations measured by two oral glucose tolerance tests in a general Caucasian population: the Hoorn Study. Diabetologia 1996;39(3):298–305.

    Article  PubMed  CAS  Google Scholar 

  37. Feskens EJ, Bowles CH, Kromhout D. Intra-and interindividual variability of glucose tolerance in an elderly population. J Clin Epidemiol 1991;44(9):947–953.

    Article  PubMed  CAS  Google Scholar 

  38. McDonald GW, Fisher GF, Burnham C. Reproducibility of the oral glucose tolerance test. Diabetes 1965;14:473–480.

    PubMed  CAS  Google Scholar 

  39. Ko GT, Chan JC, Woo J, et al. The reproducibility and usefulness of the oral glucose tolerance test in screening for diabetes and other cardiovascular risk factors. Ann Clin Biochem 1998;35(Pt 1):62–67.

    PubMed  Google Scholar 

  40. Wang W, Lee ET, Fabsitz R, Welty TK, Howard BV. Using HbA(1c) to improve efficacy of the American Diabetes Association fasting plasma glucose criterion in screening for new type 2 diabetes in American Indians: The Strong Heart Study. Diabetes Care 2002;25(8):1365–1370.

    Article  PubMed  Google Scholar 

  41. Masharani U, Karam JH. Pancreatic hormones & Diabetes mellitus. In: Greenspan FS, Gardner DG, eds. Basic & Clinical Endocrinology. McGraw-Hill, New York, 2001, 623–698.

    Google Scholar 

  42. Picardi A, Pozzilli P. Dynamic tests in the clinical management of diabetes. J Endocrinol Invest 2003;26(Suppl 7):99–106.

    PubMed  CAS  Google Scholar 

  43. American Diabetes Association. Tests of glycemia in diabetes. Diabetes Care 2001;24(Suppl 1):S80–S82.

    Google Scholar 

  44. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329(14):977–986.

    Article  Google Scholar 

  45. Kilpatrick ES, Maylor PW, Keevil BG. Biological variation of glycated hemoglobin: implications for diabetes screening and monitoring. Diabetes Care 1998;21(2):261–264.

    Article  PubMed  CAS  Google Scholar 

  46. Phillipou G, Phillips PJ. Intraindividual variation of glycohemoglobin: implications for interpretation and analytical goals. Clin Chem 1993;39(11)(Pt 1):2305–2308.

    PubMed  CAS  Google Scholar 

  47. Klein R, Klein BE, Moss SE, Davis MD, DeMets DL. Glycosylated hemoglobin predicts the incidence and progression of diabetic retinopathy. JAMA 1988;260(19):2864–2871.

    Article  PubMed  CAS  Google Scholar 

  48. The relationship of glycemic exposure (HbA1c) to the risk of development and progression of retinopathy in the diabetes control and complications trial. Diabetes 1995;44(8):968–983.

    Google Scholar 

  49. American Diabetes Association. Standards of medical care for patients with diabetes mellitus. Diabetes Care 2001;24(Suppl 1):33–43.

    Google Scholar 

  50. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1997;20(7):1183–1197.

    Google Scholar 

  51. American Diabetes Association. Postprandial blood glucose. Diabetes Care 2001;24(4):775–778.

    Article  Google Scholar 

  52. Schnedl WJ, Krause R, Halwachs-Baumann G, Trinker M, Lipp RW, Krejs GJ. Evaluation of HbA1c determination methods in patients with hemoglobinopathies. Diabetes Care 2000;23(3):339–344.

    Article  PubMed  CAS  Google Scholar 

  53. Camargo JL, Gross JL. Conditions associated with very low values of glycohaemoglobin measured by an HPLC method. J Clin Pathol 2004;57(4):346–349.

    Article  PubMed  CAS  Google Scholar 

  54. Tran HA, Silva D, Petrovsky N. Case study: potential pitfalls of using hemoglobin Alc as the sole measure of glycemic control. Clin Diabetes 2004;22:141–143.

    Article  Google Scholar 

  55. McCance DR, Hanson RL, Charles MA, et al. Comparison of tests for glycated haemoglobin and fasting and two hour plasma glucose concentrations as diagnostic methods for diabetes. BMJ 1994;308(6940):1323–1328.

    PubMed  CAS  Google Scholar 

  56. Tsuji I, Nakamoto K, Hasegawa T, et al. Receiver operating characteristic analysis on fasting plasma glucose, HbA1c, and fructosamine on diabetes screening. Diabetes Care 1991;14(11):1075–1077.

    Article  PubMed  CAS  Google Scholar 

  57. Rohlfing CL, Little RR, Wiedmeyer HM, et al. Use of GHb (HbA1c) in screening for undiagnosed diabetes in the U.S. population. Diabetes Care 2000;23(2):187–191.

    Article  PubMed  CAS  Google Scholar 

  58. Little RR, England JD, Wiedmeyer HM, et al. Relationship of glycosylated hemoglobin to oral glucose tolerance. Implications for diabetes screening. Diabetes 1988;37(1):60–64.

    Article  PubMed  CAS  Google Scholar 

  59. Barr RG, Nathan DM, Meigs JB, Singer DE. Tests of glycemia for the diagnosis of type 2 diabetes mellitus. Ann Intern Med 2002;137(4):263–272.

    PubMed  Google Scholar 

  60. Davidson MB, Schriger DL, Peters AL, Lorber B. Relationship between fasting plasma glucose and glycosylated hemoglobin: potential for false-positive diagnoses of type 2 diabetes using new diagnostic criteria. JAMA 1999;281(13):1203–1210.

    Article  PubMed  CAS  Google Scholar 

  61. Gerken KL, Van Lente F. Effectiveness of screening for diabetes. Arch Pathol Lab Med 1990;114(2):201–203.

    PubMed  CAS  Google Scholar 

  62. Guillausseau PJ, Charles MA, Paolaggi F, et al. Comparison of HbA1 and fructosamine in diagnosis of glucose-tolerance abnormalities. Diabetes Care 1990;13(8):898–900.

    Article  PubMed  CAS  Google Scholar 

  63. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet 1998;352(9131):837–853.

    Google Scholar 

  64. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 1998;15(7):539–553.

    Article  PubMed  CAS  Google Scholar 

  65. Glucose tolerance and mortality: comparison of WHO and American Diabetes Association diagnostic criteria. The DECODE study group. European Diabetes Epidemiology Group. Diabetes epidemiology: collaborative analysis of diagnostic criteria in Europe. Lancet 1999;354(9179):617–621.

    Article  Google Scholar 

  66. Meigs JB, Nathan DM, D’Agostino RB Sr, Wilson PW. Fasting and postchallenge glycemia and cardiovascular disease risk: the Framingham Offspring Study. Diabetes Care 2002;25(10):1845–1850.

    Article  PubMed  Google Scholar 

  67. Harris MI, Hadden WC, Knowler WC, Bennett PH. Prevalence of diabetes and impaired glucose tolerance and plasma glucose levels in U.S. population aged 20–74 yr. Diabetes 1987;36(4):523–534.

    Article  PubMed  CAS  Google Scholar 

  68. Harris MI, Klein R, Welborn TA, Knuiman MW. Onset of NIDDM occurs at least 4–7 yr before clinical diagnosis. Diabetes Care 1992;15(7):815–819.

    Article  PubMed  CAS  Google Scholar 

  69. American Diabetes Association. Screening for diabetes. Diabetes Care 2002;25:21–24.

    Article  Google Scholar 

  70. Verge CF, Gianani R, Kawasaki E, Yu L, et al. Prediction of type I diabetes in first-degree relatives using a combination of insulin, GAD, and ICA512bdc/IA-2 autoantibodies. Diabetes 1996;45(7):926–933.

    Article  PubMed  CAS  Google Scholar 

  71. Goldfine AB. Diagnosis and management of diabetes. In: Hall J, Nieman L, eds. Handbook of Diagnostic Endocrinology. Humana, Totowa, NJ, 2003: pp. 157–177.

    Chapter  Google Scholar 

  72. Reasner C, DeFronzo RA. Classification and Diagnosis of Diabetes Mellitus: Chapter 7. http://www.endotext.com/diabetes/diabetes1/diabetesframe1.htm, 2003.

  73. Naylor CD, Sermer M, Chen E, Farine D. Selective screening for gestational diabetes mellitus. Toronto Trihospital Gestational Diabetes Project Investigators. N Engl J Med 1997;337(22):1591–1596.

    Article  PubMed  CAS  Google Scholar 

  74. American College of Obstetrics and Gynecology (ACOG) Committee on Practice Bulletins-Obstetrics. Clinical management guidelines for obstetrician-gynecologists. Number 30, September 2001 (replaces Technical Bulletin Number 200, December 1994). Gestational diabetes. Obstet Gynecol 2001;98(3):525–538.

    Google Scholar 

  75. Jovanovic L, Pettitt DJ. Gestational diabetes mellitus. JAMA 2001;286(20):2516–2518.

    Article  PubMed  CAS  Google Scholar 

  76. Jovanovic L. Screening and Diagnosis of Gestational Diabetes Mellitus. http://patients.uptodate.com/topic.asp?file=diabetes/14302.2004. Last accessed April 26, 2005.

    Google Scholar 

  77. Jovanovic L. Achieving euglycaemia in women with gestational diabetes mellitus: current options for screening, diagnosis and treatment. Drugs 2004;64(13):1401–1417.

    Article  PubMed  CAS  Google Scholar 

  78. Monzillo LU, Hamdy O. Evaluation of insulin sensitivity in clinical practice and in research settings. Nutr Rev 2003;61(12):397–412.

    Article  PubMed  Google Scholar 

  79. Lebovitz HE. Insulin resistance: definition and consequences. Exp Clin Endocrinol Diabetes 2001;109(Suppl 2):S135–S148.

    Article  PubMed  CAS  Google Scholar 

  80. Reaven GM. Banting lecture 1988: role of insulin resistance in human disease. Diabetes 1988;37(12):1595–1607.

    Article  PubMed  CAS  Google Scholar 

  81. Einhorn D, Reaven GM, Cobin RH, et al. American College of Endocrinology position statement on the insulin resistance syndrome. Endocr Pract 2003;9(3):237–252.

    PubMed  Google Scholar 

  82. Karelis AD, St Pierre DH, Conus F, Rabasa-Lhoret R, Poehlman ET. Metabolic and body composition factors in subgroups of obesity: what do we know? J Clin Endocrinol Metab 2004;89(6):2569–2575.

    Article  PubMed  CAS  Google Scholar 

  83. Frayn KN. Visceral fat and insulin resistance—causative or correlative? Br J Nutr 2000;83(Suppl 1):71–77.

    Google Scholar 

  84. Ruderman N, Chisholm D, Pi-Sunyer X, Schneider S. The metabolically obese, normal-weight individual revisited. Diabetes 1998;47(5):699–713.

    Article  PubMed  CAS  Google Scholar 

  85. Lebovitz HE. Insulin resistance and the insulin resistance syndrome. In: Clinician’s Manual on Insulin Resistance. Science Press, London, UK, 2002: pp. 1–15.

    Google Scholar 

  86. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 2002;287(3):356–359.

    Article  PubMed  Google Scholar 

  87. Park YW, Zhu S, Palaniappan L, Heshka S, Carnethon MR, Heymsfield SB. The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988–1994. Arch Intern Med 2003;163(4):427–436.

    Article  PubMed  Google Scholar 

  88. Ford ES. Prevalence of the metabolic syndrome in US populations. Endocrinol Metab Clin North Am 2004;33(2):333–350.

    Article  PubMed  Google Scholar 

  89. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) (Adult Treatment Panel III). JAMA 2001;285(19):2486–2497.

    Google Scholar 

  90. Grundy SM, Brewer HB Jr, Cleeman JI, Smith SC Jr, Lenfant C. Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 2004;109(3):433–438.

    Article  PubMed  Google Scholar 

  91. Proceedings of the American College of Endocrinology Insulin Resistance Syndrome Conference. Washington, DC, USA. August 25–26, 2002. Endocr Pract 2003;9(Suppl 2):22–112.

    Google Scholar 

  92. Consensus Development Conference on Insulin Resistance. 5–6 November 1997. American Diabetes Association. Diabetes Care 1998;21(2):310–314.

    Google Scholar 

  93. DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 1979;237(3):214–223.

    Google Scholar 

  94. Pacini G, Bergman RN. MINMOD: a computer program to calculate insulin sensitivity and pancreatic responsivity from the frequently sampled intravenous glucose tolerance test. Comput Methods Programs Biomed 1986;23(2):113–122.

    Article  PubMed  CAS  Google Scholar 

  95. Ten S, Maclaren N. Insulin resistance syndrome in children. J Clin Endocrinol Metab 2004;89(6):2526–2539.

    Article  PubMed  CAS  Google Scholar 

  96. Reaven GM, Chen YD, Hollenbeck CB, Sheu WH, Ostrega D, Polonsky KS. Plasma insulin, C-peptide, and proinsulin concentrations in obese and nonobese individuals with varying degrees of glucose tolerance. J Clin Endocrinol Metab 1993;76(1):44–48.

    Article  PubMed  CAS  Google Scholar 

  97. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28(7):412–419.

    Article  PubMed  CAS  Google Scholar 

  98. Katz A, Nambi SS, Mather K, et al. Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab 2000;85(7):2402–2410.

    Article  PubMed  CAS  Google Scholar 

  99. Yeni-Komshian H, Carantoni M, Abbasi F, Reaven GM. Relationship between several surrogate estimates of insulin resistance and quantification of insulin-mediated glucose disposal in 490 healthy nondiabetic volunteers. Diabetes Care 2000;23(2):171–175.

    Article  PubMed  CAS  Google Scholar 

  100. Belfiore F, Iannello S, Volpicelli G. Insulin sensitivity indices calculated from basal and OGTT-induced insulin, glucose, and FFA levels. Mol Genet Metab 1998;63(2):134–141.

    Article  PubMed  CAS  Google Scholar 

  101. Matsuda M, DeFronzo RA. Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 1999;22(9):1462–1470.

    Article  PubMed  CAS  Google Scholar 

  102. Stumvoll M, Mitrakou A, Pimenta W, et al. Use of the oral glucose tolerance test to assess insulin release and insulin sensitivity. Diabetes Care 2000;23(3):295–301.

    Article  PubMed  CAS  Google Scholar 

  103. Mari A, Pacini G, Murphy E, Ludvik B, Nolan JJ. A model-based method for assessing insulin sensitivity from the oral glucose tolerance test. Diabetes Care 2001;24(3):539–548.

    Article  PubMed  CAS  Google Scholar 

  104. Gutt M, Davis CL, Spitzer SB, et al. Validation of the insulin sensitivity index (ISI(0,120)): comparison with other measures. Diabetes Res Clin Pract 2000;47(3):177–184.

    Article  PubMed  CAS  Google Scholar 

  105. Moon YS, Kim DH, Song DK. Serum tumor necrosis factor-alpha levels and components of the metabolic syndrome in obese adolescents. Metabolism 2004;53(7):863–867.

    Article  PubMed  CAS  Google Scholar 

  106. Festa A, D’Agostino R Jr, Howard G, Mykkanen L, Tracy RP, Haffner SM. Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS). Circulation 2000;102(1):42–47.

    PubMed  CAS  Google Scholar 

  107. Ridker PM, Wilson PW, Grundy SM. Should C-reactive protein be added to metabolic syndrome and to assessment of global cardiovascular risk? Circulation 2004;109(23):2818–2825.

    Article  PubMed  CAS  Google Scholar 

  108. Ridker PM, Buring JE, Cook NR, Rifai N. C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14 719 initially healthy American women. Circulation 2003;107(3):391–397.

    Article  PubMed  Google Scholar 

  109. Ridker PM, Koenig W, Fuster V. C-reactive protein and coronary heart disease. N Engl J Med 2004;351(3):295–298.

    Article  PubMed  Google Scholar 

  110. Chandran M, Phillips SA, Ciaraldi T, Henry RR. Adiponectin: more than just another fat cell hormone? Diabetes Care 2003;26(8):2442–2450.

    Article  PubMed  CAS  Google Scholar 

  111. Matsuda M, Shimomura I. Adipocytokines and metabolic syndrome—molecular mechanism and clinical implication. Nippon Rinsho 2004;62(6):1085–1090.

    PubMed  Google Scholar 

  112. Center for Disease Control and Prevention (CDC). Prevalence of diabetes and impaired fasting glucose in adults—United States, 1999–2000. MMWR Morb Wkly Rep 2003;52:833–837.

    Google Scholar 

  113. Morton CJ, ed. Guidance for treatment of adult obesity, 2nd ed. Shape up America! and the American Obesity Association, Bethesda, MD, 1998.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Endocrinology, Diabetes & Metabolism, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA

    Diana Barb MD & Christos S. Mantzoros MD, DSc

Authors
  1. Diana Barb MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Christos S. Mantzoros MD, DSc
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Division of Endocrinology, Diabetes & Metabolism, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA

    Christos S. Mantzoros MD, DSc

Rights and permissions

Reprints and permissions

Copyright information

© 2006 Humana Press Inc., Totowa, NJ

About this chapter

Cite this chapter

Barb, D., Mantzoros, C.S. (2006). Diagnosing Obesity, Diabetes Mellitus, and Insulin Resistance Syndrome. In: Mantzoros, C.S. (eds) Obesity and Diabetes. Contemporary Diabetes. Humana Press. https://doi.org/10.1007/978-1-59259-985-1_8

Download citation

  • DOI: https://doi.org/10.1007/978-1-59259-985-1_8

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-58829-538-5

  • Online ISBN: 978-1-59259-985-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation